![Thomas C. Fisher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas C. Fisher
Geen lopende functies
Loopbaan van Thomas C. Fisher
Eerdere bekende functies van Thomas C. Fisher
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Corporate Officer/Principal | - | - |
Martek Biosciences Corp.
![]() Martek Biosciences Corp. BiotechnologyHealth Technology Martek Biosciences Corp. developed, manufactured and marketed products derived from microalgae. The company was founded in 1985 and was headquartered in Columbia, MD. | Operationeel Directeur | 01-01-1991 | - |
Opleiding van Thomas C. Fisher
West Virginia University | Graduate Degree |
Waynesburg College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Operationeel
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Martek Biosciences Corp.
![]() Martek Biosciences Corp. BiotechnologyHealth Technology Martek Biosciences Corp. developed, manufactured and marketed products derived from microalgae. The company was founded in 1985 and was headquartered in Columbia, MD. | Health Technology |
DuPont Merck Pharmaceutical Co.
![]() DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Health Technology |
- Beurs
- Insiders
- Thomas C. Fisher
- Ervaring